GPCR is currently covered by 12 analysts with an average price target of $109.83. This is a potential upside of $93.7 (580.91%) from yesterday's end of day stock price of $16.13.
Structure Therapeutics's activity chart (see below) currently has 80 price targets and 84 ratings on display. The stock rating distribution of GPCR is 100% BUY.
Analysts' price targets on this stock were met 61.8% of the time, taking 278.53 days on average.
Highest price target for GPCR is $145, Lowest price target is $70, average price target is $109.83.
Most recent stock forecast was given by JONATHAN WOLLEBEN from CITIZENS on 09-Sep-2026. First documented stock forecast 28-Feb-2023.
Currently out of the existing stock ratings of GPCR, 24 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Oct-2023
$110
$93.87 (581.96%)
$110
2 months 13 days ago
(09-Sep-2026)
10/15 (66.67%)
$68.77 (166.80%)
489
Buy Since 27-Apr-2026
$111
$94.87 (588.16%)
$101
3 months 13 days ago
(09-Aug-2026)
0/2 (0%)
$57.86 (108.88%)
Buy Since 02-May-2025
$97
$80.87 (501.36%)
$100
3 months 15 days ago
(07-Aug-2026)
1/3 (33.33%)
$43.86 (82.54%)
220
Buy Since 23-Jun-2025
$70
$53.87 (333.97%)
$100
5 months 11 days ago
(11-Jun-2026)
4/7 (57.14%)
$26.7 (61.66%)
109
Buy Since 09-Apr-2024
$101
$84.87 (526.16%)
$101
5 months 15 days ago
(07-Jun-2026)
15/17 (88.24%)
$63.42 (168.76%)
409
What is GPCR (Structure Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on GPCR (Structure Therapeutics)?
Which analyst has the most public recommendations on GPCR (Structure Therapeutics)?
Which analyst is the currently most bullish on GPCR (Structure Therapeutics)?
Which analyst is the currently most reserved on GPCR (Structure Therapeutics)?